Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

World Congress of Bronchology and Interventional Pulmonology 2026

We are excited to announce that the World Congress of Bronchology and Interventional Pulmonology 2026 will be hosted by the Thoracic Society of Australia and New Zealand in the vibrant city of Melbourne, Australia. We are excited to announce that...

3rd Global Summit on Heart and Cardiovascular Care 2026

3rd Global Summit on Heart and Cardiovascular Care” (Heart Congress 2026), taking place on November 26–27, 2026, in Barcelona, Spain as a HYBRID EVENT—offering participants the flexibility to join in person or virtually from anywhere across the...

VietPharma&Tech 2026

Company (VIETFAIR) organizing The international exhibition on Pharmaceutical Manufacturing Technology - VietPharmaTech 2026 / The International Exhibition on Analytical and Laboratory Equipment in Vietnam - VietLab Expo 2024 from November 21 - 23,...

6th International Conference on Cardiology 2026

on Cardiology. Held in the vibrant city of Bangkok, Thailand, this prestigious event will take place on November 13–14, 2026. 6th International Conference on Cardiology. Held in the vibrant city of Bangkok, Thailand, this prestigious event will...

Global Pharma Supply Chain & Logistics Forum 2026

The Global Pharma Supply Chain & Logistics Forum 2026 is a premier invite-only event uniting top pharma and healthcare supply chain leaders. The Global Pharma Supply Chain & Logistics Forum 2026 is a premier invite-only event uniting top pharma...

NextGen Pharma 2026

NextGen Pharma, a premier global forum dedicated to exploring the latest innovations, emerging technologies, and future-focused strategies in the pharmaceutical industry. NextGen Pharma, a premier global forum dedicated to exploring the latest...

2nd International Conference on Drug Discovery 2026

The 2nd International Conference on Drug Discovery 2026, organized by Scisynopsis Conferences, aims to bring together researchers, scientists, industry leaders, and academicians from around the world to explore groundbreaking innovations in drug...

BD Strengthens Peripheral Vascular Innovation Leadership with Positive AGILITY Trial Results

of the AGILITY Investigational Device Exemption trial evaluating the Revello™ Vascular Covered Stent. Presented at VIVA 2026 by Sean Lyden, M.D., global lead principal investigator for AGILITY, the results demonstrated strong safety and...

Carterra Advances Drug Discovery Through New Lab-In-The-Loop Scientific Collaboration

back to refine the next round of AI-guided design – is a growing area of interest to the pharmaceutical industry. A July 2026 Leerink Partners report described lab-in-the-loop as an emerging paradigm reshaping antibody discovery. A similar William...

Risk & Compliance Pharma & Life Sciences Conference 2026

The 4th Annual Risk & Compliance Pharma & Life Sciences Conference takes place on October 1, 2026, at One America Square in London, UK. The 4th Annual Risk & Compliance Pharma & Life Sciences Conference takes place on October 1, 2026, at One...

Ro and Novo announce research collaboration to generate first-of-its-kind real-world evidence on the Wegovy® pill

real-world evidence on the Wegovy® pill. The debut research from the collaboration, presented on September 30 at EASD2026 in Milan, IT, evaluated outcomes among patients who switched from an injectable GLP-1 to the Wegovy® pill on Ro's platform. Ro...

Cresilon launched next-generation TRAUMAGEL.

device technologies, announced the launch of TRAUMAGEL®'s next generation, which officially debuts at EMS World Expo 2026 in Orlando, Florida. This next generation delivers the same gel technology as the current TRAUMAGEL in a more compact syringe...

Padagis Expands Workplace Naloxone Access by Providing Free Nasal Sprays to Qualifying Businesses

American National Standards Institute (ANSI) and the International Safety Equipment Association (ISEA), ANSI/ISEA Z308.1-2026. This new standard reflects a significant shift in how employers approach emergency preparedness, recognizing naloxone as...

StimCardio’s NeuroPulse Study Reports a Substantial Reduction in Recurrent Atrial Fibrillation Events Following Ablation Using Non-Invasive Wearable Neuromodulation

atrial fibrillation (AF) ablation. The study was selected for late-breaking clinical science presentation at HRX Live 2026 and simultaneously published in the peer-reviewed journal Heart Rhythm. The results were presented by Vivek Y. Reddy, MD,...

Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop to Improve Efficiency and Consistency in Gene Therapy Manufacturing

global company Asahi Kasei, will unveil the VANTIJ® SU-VFC Benchtop at Bioprocess International East (BPI EAST) 2026. This new VANTIJ® SU-VFC is a small-format system designed to deliver automated, single-use virus filtration for laboratory-scale...

Avenacy Launched Cyclophosphamide for Injection, USP in the U.S. Market

Cyclophosphamide for Injection, USP had U.S. sales of approximately $133 million for the twelve months ending in June 2026.¹ Indications and Contraindications Cyclophosphamide for Injection, USP is indicated for the treatment of adult and pediatric...

5th MENA Congress for Rare Diseases 2026

5th MENA Congress for Rare Diseases 2026 will take place from 3 to 5 September 2026 at Beach Rotana Hotel, Abu Dhabi, United Arab Emirates. 5th MENA Congress for Rare Diseases 2026 will take place from 3 to 5 September 2026 at Beach Rotana Hotel,...

New HCPCS Billing Code Enables Medicare Reimbursement for Lasix® ONYU When Furnished Incident to a Physician’s Service

(Lasix ONYU), 1 mg"), for its product Lasix® ONYU (furosemide injection). The code was published as part of CMS' Q3 2026 HCPCS Level II Coding Cycle update, released September 1, 2026, and takes effect October 1, 2026. The new code for Lasix ONYU...

Karyopharm Files Supplemental New Drug Application with FDA for XPOVIO® (Selinexor) in Combination with Ruxolitinib for the Treatment of Myelofibrosis

the FDA's decision on sNDA filing acceptance and, if accepted, the anticipated review timelines in the fourth quarter of 2026, following the FDA's 60-day filing review period. In May 2022, the FDA granted selinexor Orphan Drug Designation for the...

U.S. FDA Approves Ziihera® (zanidatamab-hrii), With or Without Tislelizumab Plus Chemotherapy, for the First-Line Treatment of HER2-Positive Advanced Gastroesophageal Adenocarcinoma

Phase 3 HERIZON-GEA-01 trial, which were published in the New England Journal of Medicine and first presented at ASCO GI 2026, with PD-L1 subgroup data presented at ASCO 2026. The trial remains ongoing, with additional analyses planned. Key...

Results 1 - 20 of 106